ROBERT W.A. SELLERS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT W.A. SELLERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT W.A. SELLERS. ROBERT W.A. SELLERS is VP, Corporate Controller in Edwards Lifesciences Corp ($EW).
Latest Insider Trading Transactions of ROBERT W.A. SELLERS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 90.40 | 274 | 24,770 | 10,760 | 11 K to 10.8 K (-2.48 %) |
May 11 2021 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 91.75 | 133 | 12,203 | 11,034 | 11.2 K to 11 K (-1.19 %) |
May 06 2021 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | A | 93.31 | 4,250 | 396,568 | 4,250 | |
May 06 2021 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Grant | A | 0.00 | 1,340 | 0 | 11,167 | 9.8 K to 11.2 K (+13.64 %) |
Apr 23 2021 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 97.66 | 12,000 | 1,171,976 | 20,409 | 32.4 K to 20.4 K (-37.03 %) |
Apr 23 2021 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 97.66 | 12,000 | 1,171,976 | 20,409 | 32.4 K to 20.4 K (-37.03 %) |
Aug 27 2020 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 21.76 | 21,540 | 468,710 | 0 | |
Aug 27 2020 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 82.60 | 21,540 | 1,779,161 | 42,040 | 63.6 K to 42 K (-33.88 %) |
Aug 27 2020 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 21.76 | 21,540 | 468,710 | 63,580 | 42 K to 63.6 K (+51.24 %) |
May 08 2020 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | A | 218.04 | 1,700 | 370,668 | 1,700 | |
May 08 2020 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Grant | A | 0.00 | 515 | 0 | 14,118 | 13.6 K to 14.1 K (+3.79 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 35.79 | 7,297 | 261,123 | 0 | |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 41.94 | 10,120 | 424,433 | 0 | |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 211.41 | 4,992 | 1,055,357 | 13,535 | 18.5 K to 13.5 K (-26.94 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 212.30 | 4,800 | 1,019,037 | 18,527 | 23.3 K to 18.5 K (-20.58 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 209.99 | 4,625 | 971,184 | 23,327 | 28 K to 23.3 K (-16.55 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 213.12 | 3,000 | 639,362 | 27,952 | 31 K to 28 K (-9.69 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 35.79 | 7,297 | 261,123 | 30,952 | 23.7 K to 31 K (+30.85 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 41.94 | 10,120 | 424,433 | 23,655 | 13.5 K to 23.7 K (+74.77 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 35.79 | 7,297 | 261,123 | 0 | |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 41.94 | 10,120 | 424,433 | 0 | |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 211.41 | 4,992 | 1,055,357 | 13,535 | 18.5 K to 13.5 K (-26.94 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 212.30 | 4,800 | 1,019,037 | 18,527 | 23.3 K to 18.5 K (-20.58 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 209.99 | 4,625 | 971,184 | 23,327 | 28 K to 23.3 K (-16.55 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 213.12 | 3,000 | 639,362 | 27,952 | 31 K to 28 K (-9.69 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 35.79 | 7,297 | 261,123 | 30,952 | 23.7 K to 31 K (+30.85 %) |
Jul 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 41.94 | 10,120 | 424,433 | 23,655 | 13.5 K to 23.7 K (+74.77 %) |
May 14 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 178.17 | 143 | 25,478 | 13,447 | 13.6 K to 13.4 K (-1.05 %) |
May 14 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 181.10 | 85 | 15,394 | 13,590 | 13.7 K to 13.6 K (-0.62 %) |
Apr 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 42.73 | 821 | 35,077 | 0 | |
Apr 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 42.73 | 821 | 35,077 | 0 | |
Apr 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 175.36 | 821 | 143,971 | 13,355 | 14.2 K to 13.4 K (-5.79 %) |
Apr 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 175.36 | 821 | 143,971 | 13,355 | 14.2 K to 13.4 K (-5.79 %) |
Apr 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 42.73 | 821 | 35,077 | 14,176 | 13.4 K to 14.2 K (+6.15 %) |
Apr 26 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 42.73 | 821 | 35,077 | 14,176 | 13.4 K to 14.2 K (+6.15 %) |
Feb 22 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 35.79 | 500 | 17,893 | 7,297 | |
Feb 22 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 175.04 | 500 | 87,519 | 13,282 | 13.8 K to 13.3 K (-3.63 %) |
Feb 22 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 35.79 | 500 | 17,893 | 13,782 | 13.3 K to 13.8 K (+3.76 %) |
Feb 22 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 35.79 | 500 | 17,893 | 7,297 | |
Feb 22 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 175.04 | 500 | 87,519 | 13,282 | 13.8 K to 13.3 K (-3.63 %) |
Feb 22 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 35.79 | 500 | 17,893 | 13,782 | 13.3 K to 13.8 K (+3.76 %) |
Feb 21 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 35.79 | 2,623 | 93,864 | 7,797 | |
Feb 21 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 175.08 | 2,623 | 459,223 | 13,282 | 15.9 K to 13.3 K (-16.49 %) |
Feb 21 2019 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 35.79 | 2,623 | 93,864 | 15,905 | 13.3 K to 15.9 K (+19.75 %) |
Nov 23 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 42.73 | 2,600 | 111,085 | 821 | |
Nov 23 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 42.73 | 5,259 | 224,691 | 3,421 | |
Nov 23 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 153.18 | 2,600 | 398,273 | 13,282 | 15.9 K to 13.3 K (-16.37 %) |
Nov 23 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 42.73 | 2,600 | 111,085 | 15,882 | 13.3 K to 15.9 K (+19.58 %) |
Nov 23 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 153.14 | 5,259 | 805,385 | 13,282 | 18.5 K to 13.3 K (-28.36 %) |
Nov 23 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 42.73 | 5,259 | 224,691 | 18,541 | 13.3 K to 18.5 K (+39.59 %) |
May 21 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | A | 135.83 | 3,070 | 416,998 | 3,070 | |
May 21 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Grant | A | 0.00 | 420 | 0 | 13,161 | 12.7 K to 13.2 K (+3.30 %) |
May 16 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 138.11 | 201 | 27,760 | 12,741 | 12.9 K to 12.7 K (-1.55 %) |
May 10 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 136.09 | 238 | 32,389 | 12,942 | 13.2 K to 12.9 K (-1.81 %) |
Feb 06 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 44.62 | 8,120 | 362,274 | 0 | |
Feb 06 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 130.58 | 5,657 | 738,709 | 13,093 | 18.8 K to 13.1 K (-30.17 %) |
Feb 06 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 131.66 | 2,500 | 329,160 | 18,750 | 21.3 K to 18.8 K (-11.76 %) |
Feb 06 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 131.47 | 2,463 | 323,801 | 21,250 | 23.7 K to 21.3 K (-10.39 %) |
Feb 06 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 130.90 | 1,400 | 183,265 | 23,713 | 25.1 K to 23.7 K (-5.57 %) |
Feb 06 2018 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 44.62 | 8,120 | 362,274 | 25,113 | 17 K to 25.1 K (+47.78 %) |
May 17 2017 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 110.59 | 322 | 35,610 | 16,852 | 17.2 K to 16.9 K (-1.87 %) |
May 09 2017 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 110.58 | 311 | 34,390 | 16,629 | 16.9 K to 16.6 K (-1.84 %) |
Apr 28 2017 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 25.48 | 12,960 | 330,221 | 0 | |
Apr 28 2017 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 109.50 | 12,960 | 1,419,120 | 16,940 | 29.9 K to 16.9 K (-43.34 %) |
Apr 28 2017 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 25.48 | 12,960 | 330,221 | 29,900 | 16.9 K to 29.9 K (+76.51 %) |
Aug 01 2016 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 114.33 | 10,000 | 1,143,342 | 16,782 | 26.8 K to 16.8 K (-37.34 %) |
May 18 2016 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 102.99 | 222 | 22,864 | 26,640 | 26.9 K to 26.6 K (-0.83 %) |
May 16 2016 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | A | 105.59 | 4,090 | 431,863 | 4,090 | |
May 16 2016 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Grant | A | 0.00 | 525 | 0 | 26,862 | 26.3 K to 26.9 K (+1.99 %) |
May 11 2016 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 105.74 | 116 | 12,266 | 26,337 | 26.5 K to 26.3 K (-0.44 %) |
Nov 23 2015 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 31.47 | 4,800 | 151,056 | 0 | |
Nov 23 2015 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 157.13 | 4,800 | 754,224 | 13,158 | 18 K to 13.2 K (-26.73 %) |
Nov 23 2015 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 31.47 | 4,800 | 151,056 | 17,958 | 13.2 K to 18 K (+36.48 %) |
May 18 2015 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | A | 130.56 | 3,590 | 468,710 | 3,590 | |
May 18 2015 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Grant | A | 0.00 | 425 | 0 | 13,015 | 12.6 K to 13 K (+3.38 %) |
May 13 2015 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 127.07 | 50 | 6,354 | 12,590 | 12.6 K to 12.6 K (-0.40 %) |
May 12 2015 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 126.40 | 56 | 7,078 | 12,640 | 12.7 K to 12.6 K (-0.44 %) |
Nov 13 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 27.77 | 3,400 | 94,418 | 0 | |
Nov 13 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 124.27 | 3,400 | 422,529 | 12,567 | 16 K to 12.6 K (-21.29 %) |
Nov 13 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 27.77 | 3,400 | 94,418 | 15,967 | 12.6 K to 16 K (+27.05 %) |
Aug 01 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 91.47 | 8,850 | 809,545 | 12,509 | 21.4 K to 12.5 K (-41.43 %) |
May 14 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 86.19 | 83 | 7,154 | 21,218 | 21.3 K to 21.2 K (-0.39 %) |
May 14 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Payment of Exercise | F | 85.39 | 51 | 4,355 | 21,301 | 21.4 K to 21.3 K (-0.24 %) |
May 12 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | A | 83.88 | 5,060 | 424,433 | 5,060 | |
May 12 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Grant | A | 0.00 | 625 | 0 | 21,352 | 20.7 K to 21.4 K (+3.02 %) |
Apr 09 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 24.42 | 1,650 | 40,293 | 0 | |
Apr 09 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 73.61 | 1,650 | 121,460 | 20,727 | 22.4 K to 20.7 K (-7.37 %) |
Apr 09 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 24.42 | 1,650 | 40,293 | 22,377 | 20.7 K to 22.4 K (+7.96 %) |
Mar 07 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Option Exercise | M | 24.42 | 1,650 | 40,293 | 1,650 | |
Mar 07 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 72.39 | 901 | 65,221 | 20,570 | 21.5 K to 20.6 K (-4.20 %) |
Mar 07 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Sell | S | 73.47 | 749 | 55,028 | 21,471 | 22.2 K to 21.5 K (-3.37 %) |
Mar 07 2014 | EW | Edwards Lifescienc ... | SELLERS ROBERT W.A. | VP, Corporate Contr ... | Buy | M | 24.42 | 1,650 | 40,293 | 22,220 | 20.6 K to 22.2 K (+8.02 %) |
Page: 1